Table 2.
Characteristics of symptomatic participants and cases infected with SARS-CoV-2.
| Total | SARS-CoV-2 | ||
|---|---|---|---|
| Positive | Negative | ||
| N | 790 | 51 | 739 |
| Days from symptom onset to sample collection [IQR] | 2.0 [1.0, 3.0] | 3.0 [2.0, 5.0] | 2.0 [1.0, 3.0] |
| Signs and symptoms | |||
| Fever | 628 (79.5) | 41 (80.4) | 587 (79.4) |
| Cough/sputum production | 255 (32.3) | 31 (60.8) | 224 (30.3) |
| Runny nose/nasal congestion | 185 (23.4) | 18 (35.3) | 167 (22.6) |
| Loss of taste or smell | 32 (4.1) | 14 (27.5) | 18 (2.4) |
| Dyspnea | 7 (0.9) | 2 (3.9) | 5 (0.7) |
| Fatigue | 105 (13.3) | 10 (19.6) | 95 (12.9) |
| Diarrhea | 48 (6.1) | 1 (2.0) | 47 (6.4) |
| Sore throat | 210 (26.6) | 19 (37.3) | 191 (25.8) |
| Headache | 121 (15.3) | 11 (21.6) | 110 (14.9) |
IQR interquartile range.